INO-9112 / Inovio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INO-9112 / Inovio
NCT02431312: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

Completed
1
90
US, RoW
INO-1800, INO-9112, Nucleos(t)ide Analogue Treatment
Inovio Pharmaceuticals
Hepatitis B
05/18
05/18
NCT05430958: Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Withdrawn
1
0
NA
INO-4800, INO-9112, CELLECTRA® 2000
Inovio Pharmaceuticals
Coronavirus Infection
03/24
03/24

Download Options